Global Measles Vaccine Market Insights, Forecast to 2025

Global Measles Vaccine market is anticipated to grow at a CAGR of XX% by 2023, according to a new report published by Marketintelligencedata Inc. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography (North America, Europe, Asia-Pacific, MEA and South America).

The Global Market for Measles Vaccine to 2023 offers detailed coverage of guanidine Measles Vaccine industry and presents main market trends. The market research gives historical and forecast market size, demand and production forecasts, end-use demand details, price trends, and company shares of the leading Measles Vaccine producers to provide exhaustive coverage of the guanidine carbonate.

This research report includes following contents:

  • Measles Vaccine Product details, including pictures and technical specifications
  • Measles Vaccine manufacturers, distributors and channels
  • Major players present in the Measles Vaccine
  • Information on competitor market shares, revenue, unit sales etc
  • Breakdown by applications for the Market
  • Value chain and distributor details in the market

Key vendors:

  • GSK
  • Sanofi-Pasteur
  • Merck
  • Serum Institute of India
  • China National Biotech Group
  • Bavarian Nordic
  • Emergent Biosolutions
  • GlaxoSmithKline
  • Medimmune
  • Johnson & Johnson
  • CSL Limited
  • Novartis
  • Pfizer

Key regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Malaysia, Philippines, Thailand, Vietnam, Europe, Germany, France, UK, Italy, Spain, Russia, Central & South America, Brazil, Rest of Central & South America, Middle East & Africa, GCC Countries, Turkey, Egypt, South Africa

Additionally, the market is segmented by the following sectors

  • Mumps Measles Rubella Vaccine, Live (MMR-II)
  • Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

Not only this, figures covering the end user applications are also provided according to the following classification

  • Children
  • Adults

In summary, the report serves to study and analyse the Measles Vaccine size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Measles Vaccine, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Overall the report is an excellent source for managers, researches and top executives alike to analyse and get clarity on the market standings and business forecast. We provide the information after thorough research and analysis saving precious hours and budget for the companies. We have been serving major clients like Sony, BCG, PWC, Mck, Hewlett Packard, Technicolor Etc.

  • 1 Study Coverage
    • 1.1 Measles Vaccine Product
    • 1.2 Key Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Measles Vaccine Market Size Growth Rate by Type
      • 1.4.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
      • 1.4.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
    • 1.5 Market by Application
      • 1.5.1 Global Measles Vaccine Market Size Growth Rate by Application
      • 1.5.2 Children
      • 1.5.3 Adults
    • 1.6 Study Objectives
    • 1.7 Years Considered
  • 2 Executive Summary
    • 2.1 Global Measles Vaccine Market Size
      • 2.1.1 Global Measles Vaccine Revenue 2016-2025
      • 2.1.2 Global Measles Vaccine Sales 2016-2025
    • 2.2 Measles Vaccine Growth Rate by Regions
      • 2.2.1 Global Measles Vaccine Sales by Regions
      • 2.2.2 Global Measles Vaccine Revenue by Regions
  • 3 Breakdown Data by Manufacturers
    • 3.1 Measles Vaccine Sales by Manufacturers
      • 3.1.1 Measles Vaccine Sales by Manufacturers
      • 3.1.2 Measles Vaccine Sales Market Share by Manufacturers
      • 3.1.3 Global Measles Vaccine Market Concentration Ratio (CR5 and HHI)
    • 3.2 Measles Vaccine Revenue by Manufacturers
      • 3.2.1 Measles Vaccine Revenue by Manufacturers (2016-2018)
      • 3.2.2 Measles Vaccine Revenue Share by Manufacturers (2016-2018)
    • 3.3 Measles Vaccine Price by Manufacturers
    • 3.4 Measles Vaccine Manufacturing Base Distribution, Product Types
      • 3.4.1 Measles Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Measles Vaccine Product Category
      • 3.4.3 Date of International Manufacturers Enter into Measles Vaccine Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 4 Breakdown Data by Type
    • 4.1 Global Measles Vaccine Sales by Type
    • 4.2 Global Measles Vaccine Revenue by Type
    • 4.3 Measles Vaccine Price by Type
  • 5 Breakdown Data by Application
    • 5.1 Overview
    • 5.2 Global Measles Vaccine Breakdown Data by Application
  • 6 North America
    • 6.1 North America Measles Vaccine by Countries
      • 6.1.1 North America Measles Vaccine Sales by Countries
      • 6.1.2 North America Measles Vaccine Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Measles Vaccine by Type
    • 6.3 North America Measles Vaccine by Application
    • 6.4 North America Measles Vaccine by Company
  • 7 Europe
    • 7.1 Europe Measles Vaccine by Countries
      • 7.1.1 Europe Measles Vaccine Sales by Countries
      • 7.1.2 Europe Measles Vaccine Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Measles Vaccine by Type
    • 7.3 Europe Measles Vaccine by Application
    • 7.4 Europe Measles Vaccine by Company
  • 8 Asia Pacific
    • 8.1 Asia Pacific Measles Vaccine by Countries
      • 8.1.1 Asia Pacific Measles Vaccine Sales by Countries
      • 8.1.2 Asia Pacific Measles Vaccine Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Measles Vaccine by Type
    • 8.3 Asia Pacific Measles Vaccine by Application
    • 8.4 Asia Pacific Measles Vaccine by Company
  • 9 Central & South America
    • 9.1 Central & South America Measles Vaccine by Countries
      • 9.1.1 Central & South America Measles Vaccine Sales by Countries
      • 9.1.2 Central & South America Measles Vaccine Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Measles Vaccine by Type
    • 9.3 Central & South America Measles Vaccine by Application
    • 9.4 Central & South America Measles Vaccine by Company
  • 10 Middle East and Africa
    • 10.1 Middle East and Africa Measles Vaccine by Countries
      • 10.1.1 Middle East and Africa Measles Vaccine Sales by Countries
      • 10.1.2 Middle East and Africa Measles Vaccine Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Measles Vaccine by Type
    • 10.3 Middle East and Africa Measles Vaccine by Application
    • 10.4 Middle East and Africa Measles Vaccine by Company
  • 11 Company Profiles
    • 11.1 GSK
      • 11.1.1 GSK Company Details
      • 11.1.2 Company Description
      • 11.1.3 Sales, Revenue and Gross Margin of Measles Vaccine
      • 11.1.4 Measles Vaccine Product Description
      • 11.1.5 Recent Development
    • 11.2 Sanofi-Pasteur
      • 11.2.1 Sanofi-Pasteur Company Details
      • 11.2.2 Company Description
      • 11.2.3 Sales, Revenue and Gross Margin of Measles Vaccine
      • 11.2.4 Measles Vaccine Product Description
      • 11.2.5 Recent Development
    • 11.3 Merck
      • 11.3.1 Merck Company Details
      • 11.3.2 Company Description
      • 11.3.3 Sales, Revenue and Gross Margin of Measles Vaccine
      • 11.3.4 Measles Vaccine Product Description
      • 11.3.5 Recent Development
    • 11.4 Serum Institute of India
      • 11.4.1 Serum Institute of India Company Details
      • 11.4.2 Company Description
      • 11.4.3 Sales, Revenue and Gross Margin of Measles Vaccine
      • 11.4.4 Measles Vaccine Product Description
      • 11.4.5 Recent Development
    • 11.5 China National Biotech Group
      • 11.5.1 China National Biotech Group Company Details
      • 11.5.2 Company Description
      • 11.5.3 Sales, Revenue and Gross Margin of Measles Vaccine
      • 11.5.4 Measles Vaccine Product Description
      • 11.5.5 Recent Development
    • 11.6 Bavarian Nordic
      • 11.6.1 Bavarian Nordic Company Details
      • 11.6.2 Company Description
      • 11.6.3 Sales, Revenue and Gross Margin of Measles Vaccine
      • 11.6.4 Measles Vaccine Product Description
      • 11.6.5 Recent Development
    • 11.7 Emergent Biosolutions
      • 11.7.1 Emergent Biosolutions Company Details
      • 11.7.2 Company Description
      • 11.7.3 Sales, Revenue and Gross Margin of Measles Vaccine
      • 11.7.4 Measles Vaccine Product Description
      • 11.7.5 Recent Development
    • 11.8 GlaxoSmithKline
      • 11.8.1 GlaxoSmithKline Company Details
      • 11.8.2 Company Description
      • 11.8.3 Sales, Revenue and Gross Margin of Measles Vaccine
      • 11.8.4 Measles Vaccine Product Description
      • 11.8.5 Recent Development
    • 11.9 Medimmune
      • 11.9.1 Medimmune Company Details
      • 11.9.2 Company Description
      • 11.9.3 Sales, Revenue and Gross Margin of Measles Vaccine
      • 11.9.4 Measles Vaccine Product Description
      • 11.9.5 Recent Development
    • 11.10 Johnson & Johnson
      • 11.10.1 Johnson & Johnson Company Details
      • 11.10.2 Company Description
      • 11.10.3 Sales, Revenue and Gross Margin of Measles Vaccine
      • 11.10.4 Measles Vaccine Product Description
      • 11.10.5 Recent Development
    • 11.11 CSL Limited
    • 11.12 Novartis
    • 11.13 Pfizer
  • 12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    • 12.1 Market Opportunities and Drivers
    • 12.2 Market Challenges
    • 12.3 Market Risks/Restraints
    • 12.4 Key World Economic Indicators
  • 13 Value Chain and Sales Channels Analysis
    • 13.1 Value Chain Analysis
      • 13.1.1 Typical Suppliers of Key Measles Vaccine Raw Material
      • 13.1.2 Measles Vaccine Customers
    • 13.2 Sales Channels Analysis
      • 13.2.1 Sales Channels Analysis
      • 13.2.2 Distributors
  • 14 Research Findings and Conclusion
  • 15 Appendix
    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
        • 15.1.1.1 Research Programs/Design
        • 15.1.1.2 Market Size Estimation
        • 15.1.1.3 Market Breakdown and Data Triangulation
      • 15.1.2 Data Source
        • 15.1.2.1 Secondary Sources
        • 15.1.2.2 Primary Sources
    • 15.2 Author Details
    • 15.3 Disclaimer

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Our Happy Customers